Nuclear Imaging Applications in Dentistry

Yıl 2024, , 562 - 569, 24.09.2024

Çağrı Erdoğdu , Gülsün Akay

https://doi.org/10.54617/adoklinikbilimler.1427368

Öz

This review discusses the indications, limitations, and diagnostic implications of nuclear imaging in the oral and maxillofacial region. In contrast to conventional imaging modalities, such as panoramic radiography and cone beam computed tomography, nuclear medicine offers unique information specific to the functional aspects of oral and maxillofacial tissues. This study aims to emphasize the current and potential applications of nuclear imaging methods in dentistry to increase dentists' knowledge of functional imaging methods and gain a different perspective, as well as their effects on diagnostic accuracy, treatment planning, and treatment outcomes. Future research will allow for a detailed evaluation of the effectiveness and reliability of nuclear imaging technologies in dentistry.

Anahtar Kelimeler

Dentistry, Molecular Imaging, Positron-Emission Tomography, Single-Photon Emission Computerized Tomography

Diş Hekimliğinde Nükleer Görüntüleme Uygulamaları

Öz

Bu derlemenin amacı oral ve maksillofasiyal bölgede nükleer görüntüleme endikasyonlarını, uygulama ile ilgili sınırlamaları ve tanısal sonuçlarını tartışmaktır. Diş hekimliğinde geleneksel görüntüleme yöntemleri olan röntgen ve konik ışınlı bilgisayarlı tomografi yöntemlerine karşılık, nükleer tıp, ağız ve çene-yüz dokularının fonksiyonel yönlerine özgü eşsiz bilgiler sunmaktadır. Ayrıca nükleer görüntüleme yöntemlerinin diş hekimliğindeki mevcut ve potansiyel uygulamaları vurgulanarak, teşhis doğruluğu, tedavi planlaması ve tedavi sonuçları üzerindeki etkileri ile birlikte diş hekimlerinin de fonksiyonel görüntüleme yöntemleri üzerindeki bilgi düzeylerini arttırmak ve farklı bir bakış açısı kazandırmak da amaçlanmıştır. Gelecekte yapılacak araştırmalar, diş hekimliğinde nükleer görüntüleme teknolojilerinin etkinliği ve güvenirliliğinin detaylı bir şekilde değerlendirilmesine olanak sağlayacaktır.

Anahtar Kelimeler

Diş Hekimliği, Moleküler Görüntüleme, Pozitron Emisyon Tomografisi, Tek Foton Emisyon Bilgisayarlı Tomografi

Kaynakça

• Mettler FA, Guiberteau MJ. Essentials of Nuclear Medicine Imaging. 6th ed. Philadelphia: W.B. Saunders; 2012. p. 1-21,3-69,271-314
• Lundberg TM, Gray PJ, Bartlett ML. Measuring and minimizing the radiation dose to nuclear medicine technologists. J Nucl Med Technol. 2002;30:25-30.
• Crișan G, Moldovean-Cioroianu NS, Timaru DG, Andrieș G, Căinap C, Chiș V. Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade. Int J Mol Sci. 2022;23.
• van Sluis J, Borra R, Tsoumpas C, van Snick JH, Roya M, Ten Hove D, et al. Extending the clinical capabilities of short- and long-lived positron-emitting radionuclides through high sensitivity PET/CT. Cancer Imaging. 2022;22:69.
• Farnworth AL, Bugby SL. Intraoperative Gamma Cameras: A Review of Development in the Last Decade and Future Outlook. J Imaging. 2023;9:102.
• Montilla-Soler JL, Makanji R. Skeletal Scintigraphy. Cancer Control. 2017;24:137-46.
• Rinaldi D, Montalto L. Scintillator Crystals: Structure, Characterization and Models for Better Performances. Crystals. 2020;10:96.
• Ferreira RI, de Almeida SM, Bóscolo FN, Santos AO, Camargo EE. Bone scintigraphy as an adjunct for the diagnosis of oral diseases. J Dent Educ. 2002;66:1381-7.
• Harada H, Takinami S, Makino S, Kitada H, Yamashita T, Notani K, et al. Three-phase bone scintigraphy and viability of vascularized bone grafts for mandibular reconstruction. Int J Oral Maxillofac Surg. 2000;29:280-4.
• Jo JH, Bae S, Gil J, Oh D, Park S, Cheon GJ, Park JW. Limited implication of initial bone scintigraphy on long-term condylar bone change in temporomandibular disorders-Comparison with cone beam computed tomography at 1 year. J Oral Rehabil. 2021;48:880-90.
• Arrago JP, Rain JD, Brocheriou C, Rocher F. Scintigraphy of the salivary glands in Sjögen's syndrome. J Clin Pathol. 1987;40:1463-7.
• Klutmann S, Bohuslavizki KH, Kröger S, Bleckmann C, Brenner W, Mester J, Clausen M. Quantitative salivary gland scintigraphy. J Nucl Med Technol. 1999;27:20-6.
• Knoll P, Krotla G, Bastati B, Koriska K, Mirzaei S. Improved quantification of salivary gland scintigraphy by means of factor analysis. Iran J of Nucl Med. 2012;20:5-10.
• Luk WH, Yeung JTH, Fung EPY, Lok CM, Ng YM. Salivary Gland Scintigraphy in Patients with Sjogren's Syndrome: A local Experience with Dual-tracer. Asia Ocean J Nucl Med Biol. 2017;5:56-65.
• Nakayama M, Okizaki A, Nakajima K, Takahashi K. Approach to Diagnosis of Salivary Gland Disease from Nuclear Medicine Images. IntechOpen; 2019.
• Wassef HR, Colletti PM. Nuclear Medicine Imaging in the Dentomaxillofacial Region. Dent Clin North Am. 2018;62:491-509.
• Furr MC, Cannady S, Nance R, Wax MK. The use of nuclear bone scanning after fibula free tissue transfer. Laryngoscope. 2013;123:2980-5.
• Roca I, Barber I, Fontecha CG, Soldado F. Evaluation of bone viability. Pediatr Radiol. 2013;43:393-405.
• Maurer AH. Combined imaging modalities: PET/CT and SPECT/CT. Health Phys. 2008;95:571-6.
• Hee-Jeong J, Bong-Hae C, Yun-Hoa J. Comparison of planar scintigraphy and bone SPECT with clinical findings and other imaging modalities in temporomandibular disorder patients. Imaging Sci Dent. 2004;34:91-7.
• Coutinho A, Fenyo-Pereira M, Dib LL, Lima EN. The role of SPECT/CT with 99mTc-MDP image fusion to diagnose temporomandibular dysfunction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:224-30.
• Ahn BC, Kim HJ, Lee SW, Yoo J, Choi JK, Lee J. New quantitative method for bone tracer uptake of temporomandibular joint using Tc-99m MDP skull SPECT. Ann Nucl Med. 2009;23:651-6.
• Nitzan DW, Katsnelson A, Bermanis I, Brin I, Casap N. The clinical characteristics of condylar hyperplasia: experience with 61 patients. J Oral Maxillofac Surg. 2008;66:312-8.
• Derlin T, Busch JD, Habermann CR. 99mTc-MDP SPECT/CT for assessment of condylar hyperplasia. Clin Nucl Med. 2013;38:e48-9. Hodder SC, Rees JI, Oliver TB, Facey PE, Sugar AW. SPECT bone scintigraphy in the diagnosis and management of mandibular condylar hyperplasia. Br J Oral Maxillofac Surg. 2000;38:87-93.
• Saridin CP, Raijmakers PG, Al Shamma S, Tuinzing DB, Becking AG. Comparison of different analytical methods used for analyzing SPECT scans of patients with unilateral condylar hyperactivity. Int J Oral Maxillofac Surg. 2009;38:942-6.
• Saridin CP, Raijmakers PG, Tuinzing DB, Becking AG. Comparison of planar bone scintigraphy and single photon emission computed tomography in patients suspected of having unilateral condylar hyperactivity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106:426-32.
• Bhure U, Roos JE, Pérez Lago MDS, Steurer I, Grünig H, Hug U, Strobel K. SPECT/CT arthrography. Br J Radiol. 2018;91:20170635.
• Bolouri C, Merwald M, Huellner MW, Veit-Haibach P, Kuttenberger J, Pérez-Lago M, et al. Performance of orthopantomography, planar scintigraphy, CT alone and SPECT/CT in patients with suspected osteomyelitis of the jaw. Eur J Nucl Med Mol Imaging. 2013;40:411-7.
• Courtney Slough, Pharm.D. ,, Shane C. Masters, M.D., Ph.D. ,, Robin A. Hurley, M.D. , and, Katherine H. Taber, Ph.D. Clinical Positron Emission Tomography (PET) Neuroimaging: Advantages and Limitations as a Diagnostic Tool. J Neuropsychiatry Clin Neurosci. 2016;28:A4-71.
• Bae MR, Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, et al. (18)F-FDG PET/CT versus CT/MR imaging for detection of neck lymph node metastasis in palpably node-negative oral cavity cancer. J Cancer Res Clin Oncol. 2020;146:237-44.
• Linz C, Brands RC, Herterich T, Hartmann S, Müller-Richter U, Kübler AC, et al. Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity. JAMA Netw Open. 2021;4:e217083.
• Wiggins RH, Hoffman JM, Fine GC, Covington MF, Salem AE, Koppula BR, Morton KA. PET-CT in Clinical Adult Oncology-V. Head and Neck and Neuro Oncology. Cancers (Basel). 2022;14.
• Cheng G, Alavi A. Value of 18F-FDG PET versus iliac biopsy in the initial evaluation of bone marrow infiltration in the case of Hodgkin's disease: a meta-analysis. Nucl Med Commun. 2013;34:25-31.
• Karapolat I, Kumanlıoğlu K. Impact of FDG-PET/CT for the Detection of Unknown Primary Tumours in Patients with Cervical Lymph Node Metastases. Mol Imaging Radionucl Ther. 2012;21:63-8.
• Lee J, Lee S, Kim SJ, Choi J, Baek K. Clinical utility of fluoride-18 positron emission tomography/CT in temporomandibular disorder with osteoarthritis: comparisons with 99mTc-MDP bone scan. Dentomaxillofac Radiol. 2013;42:29292350.
• Park HJ, Chang SH, Lee JW, Lee SM. Clinical utility of F-18 sodium fluoride PET/CT for estimating disease activity in patients with rheumatoid arthritis. Quant Imaging Med Surg. 2020;11:1156-69.
• Reinert CP, Pfannenberg C, Dittmann H, Gückel B, La Fougère C, Nikolaou K, Hoefert S. [18F]Fluoride Positron-Emission Tomography (PET) and [18F]FDG PET for Assessment of Osteomyelitis of the Jaw in Comparison to Computed Tomography (CT) and Magnetic Resonance Imaging (MRI): A Prospective PET/CT and PET/MRI Pilot Study. J Clin Med. 2022;11:3998.
• Fleisher KE, Raad RA, Rakheja R, Gupta V, Chan KC, Friedman KP, et al. Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw. J Oral Maxillofac Surg. 2014;72:1957-65.
• Guggenberger R, Fischer DR, Metzler P, Andreisek G, Nanz D, Jacobsen C, Schmid DT. Bisphosphonate-induced osteonecrosis of the jaw: comparison of disease extent on contrast-enhanced MR imaging, [18F] fluoride PET/CT, and conebeam CT imaging. AJNR Am J Neuroradiol. 2013;34:1242-7.
• Wilde F, Steinhoff K, Frerich B, Schulz T, Winter K, Hemprich A, et al. Positron-emission tomography imaging in the diagnosis of bisphosphonate-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107:412-9.
• Cohen C, Mekinian A, Uzunhan Y, Fauchais AL, Dhote R, Pop G, et al. 18F-fluorodeoxyglucose positron emission tomography/computer tomography as an objective tool for assessing disease activity in Sjögren's syndrome. Autoimmun Rev. 2013;12:1109-14.
• van Ginkel MS, Arends S, van der Vegt B, Nijland M, Spijkervet FKL, Vissink A, et al. FDG-PET/CT discriminates between patients with and without lymphomas in primary Sjögren's syndrome. Rheumatology (Oxford). 2023;62:3323-31.
• van Ginkel MS, Glaudemans A, van der Vegt B, Mossel E, Kroese FGM, Bootsma H, Vissink A. Imaging in Primary Sjögren's Syndrome. J Clin Med. 2020;9.
• Park ET, Kim SE. Radiography, Bone Scan, and F-18 FDG PET/CT Imaging Findings in a Patient with Paget's Disease. Nucl Med Mol Imaging. 2010;44:87-9.
• Installé J, Nzeusseu A, Bol A, Depresseux G, Devogelaer JP, Lonneux M. (18)F-fluoride PET for monitoring therapeutic response in Paget's disease of bone. J Nucl Med. 2005;46:1650-8.
• Himuro H, Kurata S, Nagata S, Sumi A, Tsubaki F, Matsuda A, et al. Imaging features in patients with SAPHO/CRMO: a pictorial review. Jpn J Radiol. 2020;38:622-9.
• Patel CN, Smith JT, Rankine JJ, Scarsbrook AF. F-18 FDG PET/CT Can Help Differentiate SAPHO Syndrome From Suspected Metastatic Bone Disease. Clinical Nuclear Medicine. 2009;34:254-7.